Blog

FOCUS-Lonza’s virus factory shows gene therapy’s Texas-sized promise – Nasdaq


Nasdaq

FOCUS-Lonza's virus factory shows gene therapy's Texas-sized promise
Nasdaq
ZURICH, April 10 (Reuters) – Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative raw materials of a medical revolution. The 121-year-old Basel-based contract manufacturer

2018-04-10 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.